Of the Field

LSX Congress USA 2026

L

SX Congress USA is where biotech companies from emerging startups to later-stage firms meet investors and pharma partners to power the next stage of growth. Attendees engage in 1:1 partnering, focused discussions on capital raising, investment strategies, commercialisation and pharma partnerships in the US life sciences sector. With tailored tracks, network…

Visit the official site
211Voices
70Underwriters
0Exhibitors
41On the bill · sessions
266Companies · in total
§I

The Voices

Programmed at LSX, in alphabetical order.
Aaron Schuchart
President and CEO · aether THERAPEUTICS
Abhijit Bhatia
Chief Operating Officer · Rakuten Medical
Abraham Kwon
Partner · Lowenstein Sandler
Adam Griffiths
Portfolio Manager, Partnering & Investment · Informa Connect
Alice Gilman
COO · R3 Biotechnologies
Ali Riazi
CEO · TheraVac Biologics
Anastasia Budinskaya
Investor · NFX
Andreas Goutopoulos
CEO & Co-Founder · Actithera
Andrew Dahl
Founder · BioMEMS Diagnostics
Andrew Lam
Managing Director, Head, Biotech Private Equity · Ally Bridge Group
Andy Lee
Co-Founder & CBO · Vincere Biosciences
Anjalee Khemlani
Host · Give it to me Straight, Doc
Anna Argo
Chief Business Officer · Cytotheryx
Anne Carter
Partner · Nova Rain Capital
Anosh Gomes
CEO & Founder · CrytonBio
Aryeh Ganz
Managing Partner · Cornucopian Capital
Audrey Warner
Co-Founder & Managing Partner · 28 Capital
Avni Bhalgat
Managing Director · Nucleate Florida
Barry Grossman
Partner · Ellenoff Grossman & Schole
Ben Comer
Chief Editor · Life Science Leader
Bernard Cooney
Partner · Casdin Capital
Bibhash Mukhopadhyay
CEO · Sapient Biotech Investments, Sapient Biotech Investments; Miletus Biotechnology

— and 189 more, by name unsung —

§II

Underwritten By

The houses behind the program. Tiers as disclosed.
Canadian Wood CouncilPlatinum
ICBAPlatinum
Latham & WatkinsPlatinum
Astley GilbertGold
AutodeskGold
Axcelead Drug Discovery Partners,Inc.Gold
BCIT - School of Construction & The EnvironmentGold
Brown RudnickGold
Ernst & YoungGold
Servier MondeGold
SkaddenGold
VRCAGold
YardiGold
ZEICGold
A&O ShearmanSilver
CMSSilver
Davis Polk & WardwellSilver
Finnegan LawSilver
Fish & RichardsonSilver
Foley HoagSilver
McDermott Will & SchulteSilver
Stout Risius Ross, LLCSilver
AeroSeal Canada Inc.Graphite
Airfoam Industries Ltd.Graphite
Archipelago Consulting Ltd.
Architectural Institute of British Columbia
Architecture Foundation of British Columbia (AFBC)
BarrierTek
BC Construction Association
BOMA Canada
Building Officials Association of BC
Building Transformations
Canadian Precast/Prestressed Concrete Institute (CPCI)
Career Education Society of BCCommunity Partner
Coast Capital SavingsGraphite
Crescent Custom YachtsGraphite
Engineers and Geoscientists BC
Fast+Epp
Finnegan
Goldluck Electronic Ltd.Graphite
§III

The Programme

Selected from 41 sessions on the bill.
  • 10:30am - 11:00am

    Words to the Wise - Raising Seed and Series A from Biotech Investors

    - Understanding what biotech investors prioritize when evaluating Seed and Series A funding opportunities - Effectively communicate your vision and scientific potential to attract …

    Biotech Startup Stage (Pre-Series A)
  • 10:30am - 11:15am

    South Florida - The Rising Life Science Hub

    South Florida is solidifying its position as a national healthcare and life sciences hub. With its strategic location, growing infrastructure, and influx of investment, the city is…

    Headliner Stage
  • 11:00am - 11:15am

    Galibra Neuroscience Showcase

    Biotech Startup Stage (Pre-Series A)
  • 11:00am - 11:40am

    Breaking into New Markets: Strategies for Global Biopharma Expansion

    - Identifying high-growth regions and market opportunities - Navigating regulatory landscapes and compliance challenges - Building strategic partnerships to accelerate market entry

    Market Opportunities & Commercialisation
  • 11:00am - 11:40am

    From Bench to Bedside: Accelerating the Translation of Breakthrough Biopharma Innovations

    - Streamlining the journey from research to clinical application - Overcoming regulatory and operational hurdles in drug development - Enhancing patient access to life-saving thera…

    Early Innovation & Technology Translation
  • 11:00am - 11:40am

    Global BioPharma Partnerships: Navigating Cross-Border Collaboration and out Licensing

    - Strategies for fostering successful cross-border collaborations in the biopharma industry - Key considerations and challenges in out-licensing agreements across global markets - …

    Pharma Partnering & Deal Making
  • 11:00am - 11:40am

    Venture Capital Trends in Biopharma: Insights into Investor Priorities

    - What’s had investors talking in 2026? - How are we thinking about innovation in the current climate - Every investor’s number one priority (or should be)

    Capital Markets & Investment Strategies
  • 11:15am - 11:30am

    AllerGene AI Therapeutics Showcase

    Biotech Startup Stage (Pre-Series A)
  • 11:15am - 12:00pm

    How to Get Funded as a Medtech Startup

    - Crafting a compelling value proposition that resonates with investors - Understanding the unique funding challenges in the medtech sector - Preparing for regulatory hurdles that …

    Medtech & Digital Health Stage
Intermission
Part the Second · For the Buyer

What does it mean when 266 companies show up — and 3 bet on three roles at once?

266 companies. three are betting more than once.

The numbers below are derived from the speakers, sponsors, and exhibitors on this page — cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

01Fig. 01 — Composition of the House
3All threespeak · spons · exh
67Sponsoringsponsor only
0Exhibitingexhibitor only
196Companies Speakingspeaker only

The Triple-Threat

Brown Rudnick·Finnegan·A&O Shearman

02Fig. 02 — The Voices, by Seniority

86% of the speakers carry senior titles — C-suite, Founder, VP, or Director-level.

  • C-suite8641%
  • Founder / Owner4722%
  • VP-level94%
  • Director / Head of3918%
  • Manager / Lead42%
  • Research / Science10%
  • Marketing / Brand10%
  • Advisor / Investor63%
  • Other roles189%

Of 211 on the bill · classified by free-text title

03Fig. 03 — The Heaviest in the Room
  1. 01Brown RudnickSp·G2V
  2. 02FinneganSp2V
  3. 03A&O ShearmanSp·S1V
  4. 04AeroSeal Canada Inc.Sp·G
  5. 05Airfoam Industries Ltd.Sp·G
  6. 06Archipelago Consulting Ltd.Sp
  7. 07Architectural Institute of British ColumbiaSp
  8. 08Architecture Foundation of British Columbia (AFBC)Sp
  9. 09Astley GilbertSp·G
  10. 10AutodeskSp·G
  11. 11Axcelead Drug Discovery Partners,Inc.Sp·G
  12. 12BarrierTekSp
  13. 13BC Construction AssociationSp
  14. 14BCIT - School of Construction & The EnvironmentSp·G
04Fig. 04 — By Tier
platinum3
4% of 70
gold11
16% of 70
silver8
11% of 70
community partner2
3% of 70
graphite21
30% of 70
unspecified25
36% of 70
05Fig. 05 — The Missing · who's at peer events but not here

These companies sponsored two or more peer events recently, but aren't on this program. For an organizer, that's a list of warm prospects.

06Fig. 06 — Adjacent Convocations · by shared underwriters